ArticleOncotarget2018

Protein biosynthesis, a target of sorafenib, interferes with the unfolded protein response (UPR) and ferroptosis in hepatocellular carcinoma cells.

Chloé Sauzay et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.